BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 932203)

  • 1. A comparative analysis of the C1-binding ability of fragments derived from complement-fixing and noncomplement-fixing IgM proteins.
    Hurst MM; Volanakis JE; Stroud RM; Bennett JC
    J Clin Invest; 1976 Jul; 58(1):16-21. PubMed ID: 932203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM.
    Hurst MM; Volanakis JE; Stroud RM; Bennett JC
    J Exp Med; 1975 Nov; 142(5):1322-6. PubMed ID: 1194853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.
    Füst G; Medgyesi GA; Rajnavölgyi E; Csécsi-Nagy M; Czikora K; Gergely J
    Immunology; 1978 Dec; 35(6):873-84. PubMed ID: 104923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of quaternary structure in the expression of the C1-binding site of IgM.
    Bubb MO; Conradie JD
    Immunology; 1976 Dec; 31(6):893-902. PubMed ID: 825451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the interaction between protein A and immunoglobulin G. I. Effect of protein A on the functional activity of IgG.
    Langone JJ; Boyle MD; Borsos T
    J Immunol; 1978 Jul; 121(1):327-32. PubMed ID: 353195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structural basis for binding of complement by immunoglobulin M.
    Hurst MM; Volanakis JE; Hester RB; Stroud RM; Bennett JC
    J Exp Med; 1974 Oct; 140(4):1117-21. PubMed ID: 4427090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative binding of a complement component to antigen-antibody complexes. III. Complexes containing IgM antibodies.
    Kuo CY; Thompson JJ; Hoffmann LG
    Z Immunitatsforsch Immunobiol; 1976 Sep; 152(2):151-66. PubMed ID: 960974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement.
    Isenman DE; Dorrington KJ; Painter RH
    J Immunol; 1975 Jun; 114(6):1726-9. PubMed ID: 1127227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the interaction between monoclonal IgM proteins and the complement system.
    Füst G; Csécsi-Nagy M; Medgyesi GA; Kulics J; Gergely J
    Immunochemistry; 1976 Oct; 13(10):793-800. PubMed ID: 12107
    [No Abstract]   [Full Text] [Related]  

  • 12. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
    Bernard A; Walter W; Teshima H; Boumsell L; Good RA; Day NK
    J Immunol; 1976 Oct; 117(4):1117-26. PubMed ID: 977945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.
    Atkinson JP; Frank MM
    J Clin Invest; 1974 Aug; 54(2):339-48. PubMed ID: 4847248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the exposure of aromatic chromophores at the surface of the Fc domains of immunoglobulin G and their ability to bind complement.
    Isenman DE; Ellerson JR; Painter RH; Dorrington KJ
    Biochemistry; 1977 Jan; 16(2):233-40. PubMed ID: 13808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):575-82. PubMed ID: 4536807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1 binding by murine IgM. The effect of a Pro-to-Ser exchange at residue 436 of the mu-chain.
    Wright JF; Shulman MJ; Isenman DE; Painter RH
    J Biol Chem; 1988 Aug; 263(23):11221-6. PubMed ID: 3136155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies in IgD--I. Complement fixing activities of IgD myeloma proteins.
    Konno T; Hirai H; Inai S
    Immunochemistry; 1975 Sep; 12(9):773-7. PubMed ID: 1193680
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of human Waldenström's IgM proteins with guinea pig and human complement.
    Ikeda M; Onoue K
    Jpn J Microbiol; 1976 Apr; 20(2):101-8. PubMed ID: 59830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1 binding by mouse IgM. The effect of abnormal glycosylation at position 402 resulting from a serine to asparagine exchange at residue 406 of the mu-chain.
    Wright JF; Shulman MJ; Isenman DE; Painter RH
    J Biol Chem; 1990 Jun; 265(18):10506-13. PubMed ID: 2113058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.